Clinical Outcomes in Musculoskeletal Involvement of Burkholderia Pseudomallei Infection

다국어 초록 (Multilingual Abstract)

Background: Musculoskeletal involvement in melioidosis is often seen in conjunction with a disseminated illness. Recent reports suggest that operative management of musculoskeletal melioidosis has favourable results. The purpose of this study was to review the patient profile and clinical outcomes of Burkholderia pseudomallei infection in the musculoskeletal system.
Methods: Hospital records of 163 patients who were diagnosed to have B. pseudomallei infection between January 2009 and December 2014 were reviewed. Patients underwent surgical and nonsurgical management depending upon the tissue of involvement.
Epidata software was used to record the data. The SPSS ver. 17.0 was used for analysis.
Results: Eighteen out of 24 patients who had musculoskeletal melioidosis were available for follow-up. Septic arthritis, osteomyelitis, and intramuscular abscess were the common diagnosis, with 6 patients in each group. Twelve patients required surgical intervention. All patients received a full course of parenteral ceftazidime followed by oral doxycycline and co-trimoxazole. Two out of 6 patients (33.3%) died among those who had nonsurgical management as compared to none in the group who had surgical management. This was significant at 10% level of significance (p = 0.098). The rest were followed up for a minimum of 1 year with no evidence of disease recurrence.
Conclusions: This series describing musculoskeletal involvement in melioidosis is the largest such study from a recently recognized ‘endemic’ region. Of importance are the patterns of musculoskeletal involvement, pitfalls in diagnosis and adequate clinical response with timely diagnosis and appropriate surgical management.

참고문헌 (Reference)

1 Chetchotisakd P, "Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis(MERTH) : a multicentre, double-blind, non-inferiority, randomised controlled trial" 383 (383): 807-814, 2014

2 Suputtamongkol Y, "The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand" 23 (23): 1082-1090, 1994

3 Chrispal A, "The clinical profile and predictors of mortality in patients with melioidosis in South India" 40 (40): 36-38, 2010

4 Ng WM, "Melioidotic osteomyelitis treated with antibiotic-calcium hydroxyapatite composite : case report with four-year follow-up" 47 (47): 71-74, 2006

5 Cheng AC, "Melioidosis in northern Australia, 2001-02" 27 (27): 272-277, 2003

6 John TJ, "Melioidosis in India:the tip of the iceberg?" 103 : 62-65, 1996

7 Raghavan KR, "Melioidosis in India" 28 (28): 184-188, 1991

8 Chaowagul W, "Melioidosis : a major cause of community-acquired septicemia in northeastern Thailand" 159 (159): 890-899, 1989

9 Punyagupta S, "Melioidosis" Bangkok Medical 217-229, 1989

10 Wiersinga WJ, "Melioidosis" 367 (367): 1035-1044, 2012

11 Subhadrabandhu T, "Localised melioidotic osteomyelitis" 77 (77): 445-449, 1995

12 Leelarasamee A, "Isolation rates of Burkholderia pseudomallei among the four regions in Thailand" 28 (28): 107-113, 1997

13 White NJ, "Halving of mortality of severe melioidosis by ceftazidime" 2 (2): 697-701, 1989

14 Currie BJ, "Endemic melioidosis in tropical northern Australia : a 10-year prospective study and review of the literature" 31 (31): 981-986, 2000

15 Pandey V, "Burkholderia pseudomallei musculoskeletal infections(melioidosis)in India" 44 (44): 216-220, 2010

16 Whitmore A, "An account of the discovery of a hitherto undescribed infectious disease among the population of Rangoon" 47 : 262-267, 1912

17 Mukhopadhyay C, "Aetiology and management of chronic granulomatous osteomyelitis: look before you leap" 48 (48): e40-e42, 2007

18 Cheng AC, "A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand" 45 (45): 308-314, 2007